Follow Us:
Lactitol Exporter From India

Lactitol

Lactitol is an osmotic laxative used to treat chronic constipation and, in selected formulations, hepatic encephalopathy. It works by drawing water into the intestine, softening stools and promoting bowel movements; in hepatic encephalopathy, it also helps reduce intestinal ammonia absorption. It is available as oral powder, granules, and syrup, depending on the market. Common side effects include abdominal bloating, flatulence, diarrhoea, nausea, and abdominal discomfort. Excessive use may cause dehydration and electrolyte imbalance, particularly in patients with prolonged diarrhoea. Lactitol should be used under medical supervision, with dosage adjusted according to the condition being treated.

  • Dosage Form:
  • Dosage Strength:
  • Manufacturer:
  • CAS No.:
  • Status:

Applications of Lactitol

Lactitol was historically used as a respiratory medicine for the symptomatic management of certain respiratory conditions. Its former uses included:

is okay

Contraindication of Lactitol

Availability of Lactitol

Delivery of Lactitol

Frequently Asked Questions

The most frequently asked questions focus on import, export, documentations, and regulation for Lactitol.

The is a pharmaceutical active pharmaceutical ingredient (API) used in manufacturing of Lactitol.

: Provides active pharmaceutical ingredients (APIs), customized production, and OEM/ODM services with research and technical cooperation across Europe, the USA, and India via Primeera Healthcare.

  • Therapeutic Goods Administration (TGA):
  • US Food and Drug Administration (USFDA):
  • European Medicines Agency (EMA):
  • African Medicines Agency (AMA):
  • National Medical Products Administration (NMPA):
  • Central Drugs Standard Control Organization (CDSCO):

Primeera Healthcare Private Limited can provide import coordination and pharmaceutical documentation assistance for Lactitol, subject to confirmation of its current regulatory status and eligibility for import into India.

Documentation Required for Lactitol Import

The import of medicines into India is regulated by the Central Drugs Standard Control Organisation (CDSCO) under the Drugs and Cosmetics Act, 1940, and the Drugs and Cosmetics Rules, 1945. The regulatory requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished formulation, or an unapproved medicine intended for an individual patient's treatment.

Import Regulations and dcoumentation for Lactitol

  • Import Documentation Assistance:
    Support with organising commercial invoices, packing lists, manufacturer details, product specifications, certificates of analysis, and other relevant documents required for regulatory review and customs processing.

  • Regulatory Coordination:
    Assistance with identifying applicable CDSCO requirements, import authorisations, and documentation procedures, subject to the product's regulatory status and the proposed import route.
  • Shipping and Customs Coordination:
    Coordination with relevant logistics providers and customs professionals to organise shipment documentation and facilitate clearance where legally permitted.
  • Compliance Verification:
    Preliminary review of available product and shipment documentation to identify potential regulatory gaps before procurement or dispatch. Import arrangements will proceed only after the applicable permissions and restrictions have been verified.

Customs Clearance and Compliance Handling of Lactitol Import

Primeera Healthcare Private Limited can provide import coordination and pharmaceutical documentation assistance for Lactitol, subject to confirmation of its current regulatory status and eligibility for import into India.

Export Regulations and dcoumentation for Lactitol

The export of Lactitol from India is subject to applicable requirements under the Drugs and Cosmetics Act, 1940, the Drugs and Cosmetics Rules, 1945, and relevant export, customs, and destination-country regulations. Documentation requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished pharmaceutical formulation, or a medicine intended for a specific market. Export eligibility and destination-country requirements must be verified before shipment.

Documentation Required for Lactitol Emport

  • Export Documentation Assistance:
    Assistance with organising commercial invoices, packing lists, manufacturer details, Lactitol specifications, certificates of analysis, and other supporting documents required for Lactitol export and customs processing.
  • Regulatory Coordination:
    Support in identifying applicable country specific Lactitol export requirements, relevant manufacturing and export authorisations, and destination-country registration or import approval requirements, subject to the Lactitol regulatory status.
  • Shipping and Customs Coordination:
    Coordination with logistics providers, freight forwarders, and customs professionals to organise shipping documentation, export declarations, and customs clearance procedures where legally permitted.
  • Compliance Verification:
    Preliminary review of available Lactitol documentation, labelling, Lactitol manufacturing information, and destination-market requirements to identify potential regulatory gaps before dispatch. Export arrangements will proceed only after the applicable restrictions and authorisations have been verified.

Customs Clearance and Compliance Handling of Lactitol Export

Primeera Healthcare Private Limited can provide pharmaceutical export documentation assistance, regulatory coordination, and shipping support for Lactitol, subject to confirmation of its export eligibility under applicable Indian regulations and the import requirements of the destination country.

Product Export Support

If you have any questions or need any help, contact our Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.

Disclaimer

All Trademarks and Brands that appear on the website belong to their respective owners. Primeera Healthcare does not lay any claim on them; we only provide information.